U.S. Health Secretary Robert F. Kennedy Jr. announced plans to reform the National Vaccine Injury Compensation Program (VICP), pledging to address what he calls inefficiencies and corruption within the system. Kennedy, a long-time vaccine skeptic and former vaccine injury lawyer, criticized the program’s “Vaccine Court” for failing to quickly and fairly compensate individuals harmed by vaccines.
In a post on X, Kennedy said he is working with Attorney General Pam Bondi to restore the program to its “original congressional intent,” arguing that its current structure unfairly positions the Department of Health and Human Services (HHS), which he leads, as the defendant rather than vaccine manufacturers.
This move continues Kennedy’s sweeping efforts to reshape U.S. vaccine and health policy. In June, he dismissed all 17 members of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, replacing them with seven appointees, including figures with histories of questioning vaccine safety. One of these members previously earned significant fees as an expert witness against Merck’s Gardasil vaccine, a case in which Kennedy played a key role.
Kennedy is also reportedly considering removing members of another influential health advisory panel, the U.S. Preventive Services Task Force. His tenure at HHS has intensified scrutiny due to his longstanding promotion of vaccine skepticism, including discredited claims linking vaccines to autism and false statements about fetal cells in the measles vaccine.
The announcement comes amid one of the worst U.S. measles outbreaks in decades, further fueling debate over vaccine safety, public health policy, and Kennedy’s leadership approach.


US Tightens AI Chip Export Rules, Impacting Nvidia and AMD Sales to Chinese Firms
ASIC Launches Formal Investigation Into KPMG Australia Partners Over Client Data Misuse Allegations
Trump Administration Defends Anthropic AI Restrictions in Ongoing Federal Lawsuit
Medicare to Cover GLP-1 Weight-Loss and Diabetes Drugs Starting July 1
France, Allies Prepare Coordinated Sanctions Over West Bank Settler Violence
RFK Jr. Faces Scrutiny Over David Geier’s HHS Role and Vaccine Review Work
SEC Tokenized Stock Approval Still Expected as Regulatory Framework Advances
Gordie Howe International Bridge Set to Open, Boosting U.S.-Canada Trade Links
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
US Imposes Fresh Iran Oil Sanctions Despite Progress on Ceasefire Talks
Armenia Election 2026: Early Results Show Ruling Civil Contract Party in Strong Lead
Switzerland Population Cap Referendum Sparks Economic and Immigration Debate
Brazil Struggles to Stop Illegal Amazon Gold Mining as Gold Prices Surge
U.S. Reinstates Sanctions on U.N. Expert Francesca Albanese Amid Legal Battle
Trump Nominates Todd Blanche for Attorney General, Setting Up Key Senate Confirmation Battle
UN Blacklists Israel and Russia Over Conflict-Related Sexual Violence Claims
Trump Urges Restraint as Israel-Iran Tensions Threaten Fragile Peace Talks 



